emerging new clinical applications for palifermin: beyond its use in oral mucositis and graft versus host disease
Clicks: 199
ID: 220306
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
199 views
24 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #15 of 61 articles by views in letters in applied microbiology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Shailendra KapoorRichmond, VA, USATo the editorI read with great interest the recent article by Barasch et al in a recent issue of your journal. The article is highly thought-provoking. Interestingly, the past few years have seen the emergence of a number of novel clinical applications of palifermin, in addition to its use in oral mucositis and graft versus host disease.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (62 words).
Try re-searching for a better abstract.
| Reference Key |
s2012biologicsemerging
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Kapoor S |
| Journal | letters in applied microbiology |
| Year | 2012 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.